Classic Home

Vaccines against
antibiotic-resistant infections

About Vaxdyn

Vaxdyn works with an international network of collaborators on development of multi-valent vaccines for preventing antibiotic-resistant infections in all regions of the world.

Products Vaxdyn

The founders of Vaxdyn have developed a platform that facilitates the rapid development of antibacterial vaccines that have broad coverage against different strains within a bacterial species.

Mission Vaxdyn

To prevent and alleviate the global health crisis caused by the pathogenic bacteria developing resistance to available antibiotics.

Latest News

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

admin2020-07-07T06:27:32+00:00julio 7th, 2020|News|

Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising threat of drug resistant bacteria

VAXDYN IS A MEMBER OF THE BEAM ALLIANCE

Vaxdyn2020-07-06T12:23:54+00:00julio 6th, 2020|News|

Vaxdyn in member of the BEAM Alliance. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong Network

VAXDYN EN EL BOLETÍN MENSUAL DE ASEBIO

Vaxdyn2020-07-06T12:23:54+00:00julio 6th, 2020|News|

El proyecto ACINETOCLINIC, financiado por la convocatoria RETOS-COLABORACIÓN 2016, se incluye en el boletin de noticias de las sociedad

We work

for your health

Preventing the next

health crisis

Biotechnology

to keep the world safe

Vaccines against
antibiotic-resistant infections

About Vaxdyn

Products Vaxdyn

Mission Vaxdyn

Latest News

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

VAXDYN IS A MEMBER OF THE BEAM ALLIANCE

VAXDYN EN EL BOLETÍN MENSUAL DE ASEBIO

We work

for your health

Preventing the next

health crisis

Biotechnology

to keep the world safe

Vaccines against antibiotic-resistant infections

About Vaxdyn

Products Vaxdyn

Mission Vaxdyn

Latest News

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

VAXDYN IS A MEMBER OF THE BEAM ALLIANCE

VAXDYN EN EL BOLETÍN MENSUAL DE ASEBIO

Vaccines against
antibiotic-resistant infections